Chest Rub

Camphor, Eucalyptus Oil, Menthol


Amazon.com Service Llc
Human Otc Drug
NDC 72288-248
Chest Rub also known as Camphor, Eucalyptus Oil, Menthol is a human otc drug labeled by 'Amazon.com Service Llc'. National Drug Code (NDC) number for Chest Rub is 72288-248. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Chest Rub drug includes Camphor (natural) - 4.8 kg/100g Eucalyptus Oil - 1.2 kg/100g Menthol - 2.6 kg/100g . The currest status of Chest Rub drug is Active.

Drug Information:

Drug NDC: 72288-248
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Chest Rub
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Camphor, Eucalyptus Oil, Menthol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Amazon.com Service Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Cream
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CAMPHOR (NATURAL) - 4.8 kg/100g
EUCALYPTUS OIL - 1.2 kg/100g
MENTHOL - 2.6 kg/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 24 Apr, 2018
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 16 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part341
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Amazon.com Service LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:N20HL7Q941
2R04ONI662
L7T10EIP3A
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
72288-248-1750 g in 1 JAR (72288-248-17)24 Apr, 2018N/ANo
72288-248-75100 g in 1 JAR (72288-248-75)24 Apr, 2018N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose cough suppressant & topical analgesic

Product Elements:

Chest rub camphor, eucalyptus oil, menthol camphor (natural) camphor (natural) eucalyptus oil eucalyptus oil menthol menthol cedar leaf oil nutmeg oil petrolatum turpentine oil thymol

Indications and Usage:

Uses on chest and throat, temporarily relieves cough due to common cold on muscles and joints, temporarily releives minor aches and pains

Warnings:

Warnings for external use only; avoid contact with eyes

Do Not Use:

Warnings for external use only; avoid contact with eyes

When Using:

When using this product do not heat microwave add to hot water or any container where heating water. may cause splattering and result in burns

Dosage and Administration:

Directions see imporatant warning under "when using this product" adults & children 2 yrs & over: rub a thick layer on chest & throat or rub on sore aching muscles cover with warm, dry cloth if desired keep clothing loose about throat/chest to help vapors reach the nose/mouth repeat up to three times per 24 hours or as directed by doctor children under 2 years of age: ask a doctor

Stop Use:

Stop use and ask a doctor if muscle aches and pains persist more than 7 days or come back cough lasts more than 7 days, comes back, or occurs with fever, rash or persistent headache. these could be signs of a serious condition

Adverse Reactions:

Adverse reaction distributed by: amazon.com services llc seattle, wa 98109 1-877-485-0385 2018 amazon.com, inc or its afiliates. all rights reserved.

Package Label Principal Display Panel:

Principal display panel solimo chest rub cough suppresant topical analgesic net wt 3.53 oz (100 g) image description


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.